Trade Mark 2090137 | IP Australia

Advanced search

Number: 2090137

IR number: 1532183

Words: REBLOZYL
Image description: 3 BUBBLES BESIDE WORD
Status: protected: Registered/protected
Priority date: 05 Mar 2020 (Convention)
Class: 5
Kind: Figurative

Goods & Services

Class 5:: Pharmaceutical preparations for use in the treatment of anemia, beta thalassemia, blood disease and cancer.

Endorsements

The mark consists of the word REBLOZYL in purple with three pink and purple dots to the right of the word.

Purple and pink.

The word REBLOZYL in purple with three pink and purple dots to the right of the word.

Convention details

Date:

05 Mar 2020

Number:

88822744

Country:

UNITED STATES OF AMERICA

Opposition details

No oppositions information available.

History and Publications

Date	Description
14 Nov 2024	Amendment to Amend Owner Requested
07 Sep 2023	Amendment to International Registration Contact Requested
14 Jul 2021	IP right goods and service classes updated	More
	Event description Class Count: 1 Class Numbers:5 Previous details Class Count: 1 Class Numbers: 5 New details Class Count: 1 Class Numbers: 5
14 Jul 2021	IP Right Goods and Services Items updated	More
	Event description Class Number: 5 Previous details Class Number: 5 Class Items: Pharmaceutical preparations for use in the treatment of anemia, beta thalassemia, myelodysplastic syndromes, autoinflammatory disease, autoimmune disease, blood disease, cancer, arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations for use in the treatment of anemia, beta thalassemia, blood disease, cancer. New details Class Number: 5 Class Items: Pharmaceutical preparations for use in the treatment of anemia, beta thalassemia, blood disease and cancer.
06 May 2021	Amendment to International Registration Contact Requested
12 Nov 2020	International Registration in Australia Protected correspondence sent
11 Nov 2020	IP Right Registration Published	Trade mark details »
11 Nov 2020	Status change to Registered/Protected
05 Sep 2020	Application Accepted correspondence sent
04 Sep 2020	IP Right has been Examined
04 Sep 2020	IP Right Acceptance Published	Trade mark details »
04 Sep 2020	Status change to Accepted
21 May 2020	Examination expedited
21 May 2020	Awaiting examination
21 May 2020	Word and image indexing completed
21 May 2020	IP Right Filed Published	Trade mark details »
21 May 2020	Status change to Published
21 May 2020	Status change to Filed
21 May 2020	IP right goods and service classes updated	More
	Event description Class Count: 1 Class Numbers:5 Previous details Class Count: 0 Class Numbers: New details Class Count: 1 Class Numbers: 5
21 May 2020	IP Right Goods and Services Items updated	More
	Event description Class Number: 5 Previous details New details Class Number: 5 Class Items: Pharmaceutical preparations for use in the treatment of anemia, beta thalassemia, myelodysplastic syndromes, autoinflammatory disease, autoimmune disease, blood disease, cancer, arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations for use in the treatment of anemia, beta thalassemia, blood disease, cancer.
21 May 2020	Status change to Received
21 May 2020	Trade mark representation updated
21 May 2020	Application Received

Dates

Renewal due: 10 Mar 2030
Registration advertised / published: 11 Nov 2020
Entered on Register: 11 Nov 2020
Acceptance advertised / published: 04 Sep 2020
Acceptance: 04 Sep 2020
IR notification: 21 May 2020
Filing: 10 Mar 2020
Registered from: 10 Mar 2020

Owner

Address for service

IR Contact

Indexing constituents

Word

REBLOZYL

Image

THREE

BUBBLE+

ROUND+

BALL+

DIVIDED